Venezuelan equine encephalitis virus vaccine candidate (V3526) safety, immunogenicity and efficacy in horses

Vaccine

Volumn 25, Issue 10, 2007, Pages 1868-1876

  Fine, Donald L ^a   Roberts, Brian A ^b   Teehee, Max L ^c   Terpening, Sara J ^a   Kelly, Cindy L H ^d   Raetz, Janae L ^d   Baker, Dale C ^c   Powers, Ann M ^d   Bowen, Richard A ^c  

^a A CSC Company   (United States)

^b U S ARMY   (United States)

^c Department of Environmental and Radiological Health Sciences   (United States)

^d NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

Equines; Vaccines; Venezuelan equine encephalitis (VEE) virus

Indexed keywords

NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG; V3526 VACCINE; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANOREXIA; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; ENCEPHALOMYELITIS; FEVER; IMMUNOGENICITY; LEUKOCYTE COUNT; LEUKOPENIA; MALAISE; NONHUMAN; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS; VACCINATION; VENEZUELAN EQUINE ENCEPHALOMYELITIS ALPHAVIRUS; VIRUS CLASSIFICATION; VIRUS STRAIN; VIRUS VIRULENCE;

ANIMALS; ENCEPHALITIS VIRUS, VENEZUELAN EQUINE; ENCEPHALOMYELITIS, VENEZUELAN EQUINE; FEMALE; HISTOCYTOCHEMISTRY; HORSE DISEASES; HORSES; INJECTIONS, SUBCUTANEOUS; KIDNEY; LEUKOCYTE COUNT; LIVER; LUNG; LYMPH NODES; MALE; MYOCARDIUM; PANCREAS; PLAQUE ASSAY; SPLEEN; TELENCEPHALON; VACCINES, ATTENUATED; VIRAL VACCINES; VIREMIA;

EID: 33846633361     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.10.030     Document Type: Article

References (30)

1. Weaver S.C., Ferro C., Barriera R., Boshell J., and Navarro J. Venezuelan equine enchephalitis. Ann Rev Entomol 49 (2004) 141-174
2. Young N.A., and Johnson K.M. Antigenic variants of Venezuelan equine encephalitis: their geographical distribution and epidemiologic significance. Am J Epidemiol 89 3 (1969) 286-307
3. Smith J.F., Davis K., Hart M.K., Ludwig G.V., McClain D.J., Parker M.D., et al. In: Sidwell R.V., Takafuji E.T., and Franz D.R. (Eds). Medical aspects of chemical and biological warfare (1997) 561-589 [chapter 28]
4. Johnson K.M., and Martin D.H. Venezuelan equine encephalitis. Adv Vet Sci Comp Med 18 (1974) 79-116
5. Davis N.L., Powell N., Greenwald G.F., Willis L.V., Johnson B.J., Smith J.F., et al. Attenuating mutations in the E2 glycoprotein gene of Venezuelan equine encephalitis virus: construction of single and multiple mutants in a full-length cDNA clone. Virology 183 1 (1991) 20-31
6. Davis N.L., Grieder F.B., Smith J.F., Greenwald G.F., Valenski M.L., Sellon D.C., et al. A molecular genetic approach to the study of Venezuelan equine encephalitis virus pathogenesis. Arch Virol Suppl 9 (1994) 99-109
7. Davis N.L., Brown K.W., Greenwald G.F., Zajac A.J., Zacny V.L., Smith J.F., et al. Attenuated mutants of Venezuelan equine encephalitis virus containing lethal mutations in the PE2 cleavage signal combined with a second-site suppressor mutation in E1. Virology 212 1 (1995) 102-110
8. Hart M.K., Lind C., Bakken R., Robertson M., Tammariello R., and Ludwig G.V. Onset and duration of protective immunity to IA/IB and IE strains of Venezuelan equine encephalitis virus in vaccinated mice. Vaccine 20 3-4 (2001) 616-622
9. Pratt W.D., Davis N.L., Johnston R.E., and Smith J.F. Genetically engineered, live attenuated vaccines for Venezuelan equine encephalitis: testing in animal models. Vaccine 21 25-26 (2003) 3854-3862
10. Reed D.S., Hart M.K., Pratt W.D., Lind C., Gallagher P., Lackenmeyer M., et al. Evaluation of a genetically modified live attenuated vaccine for Venezuelan equine encephalitis. Sixth annual conference on vaccine research (S9), May 5-7 (2003)
11. Reed D.S., Lind C.M., Lackemeyer M.G., Sullivan L.J., Pratt W.D., and Parker M.D. Genetically engineered, live, attenuated vaccines protect nonhuman primates against aerosol challenge with a virulent 1E strain of Venezuelan equine encephalitis virus. Vaccine 23 24 (2005) 3239-3247
12. Dietz W.H., Alvarez O., Martin D.H.N., Walton T.E., and Ackerman L.J. Johnson KM enzootic and epizootic Venezuelan equine encephalomyelitis virus in horses infected by peripheral and intrathecal routes. J Infect Dis 137 3 (1978) 227-237
13. Engler R.J.M., Mangiafico J.A., Jahrling P., Ksiazek T.G., Pedrotti-Krueger M., and Peters C.J. Venezuelan equine encephalitis-specific immunoglobulin responses: live attenuated TC-83 versus inactivated C-84 vaccine. J Med Virol 38 4 (1992) 305-310
14. McKinney R.W. Inactivated and live VEE vaccines-a review. Venezuelan encephalitis: proceedings of the workshop symposium on Venezuelan encephalitis virus. Publication 243, Washington, DC: Pan American Health Organization, September 14-17, 1971 (1972) 369-377
15. Casamassima A.C., Hess L.W., and Marty A. TC-83 Venezuelan equine encephalitis exposure during pregnancy. Teratology 36 3 (1987) 287-289
16. Wenger F. Venezuelan equine encephalitis. Teratology 16 (1977) 359-362
17. Edelman R., Cole Jr. F.E., May S.W., and Eddy G.A. Inactivated Venezuelan equine encephalomyelitis vaccine prepared from attenuated (TC-83 strain) virus. Appl Microbiol 27 1 (1974) 150-153
18. Edelman R., Ascher M.S., Oster C.N., Ramsburg H.H., Cole F.E., and Eddy G.A. Evaluation in humans of a new, inactivated vaccine for Venezuelan equine encephalitis virus (C84). J Infect Dis 140 5 (1979) 708-715
19. Pittman P.R., Makuch R.S., Mangiafico J.A., Cannon T.L., Gibbs P.H., and Peters C.J. Long-term duration of detectable neutralizing antibodies after administration of live-attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccine. Vaccine 14 4 (1996) 337-343
20. Walton T.E., Alvarez Jr. O., Buckwalter R.M., and Johnson K.M. Experimental infection of horses with enzootic and epizootic strains of Venezuelan equine encephalomyelitis virus. J Infect Dis 128 3 (1973) 271-282
21. Spertzel R.O., and Kahn D.E. Safety and efficacy of an attenuated Venezuelan equine encephalomyelitis vaccine for use in equidae. J Am Vet Med Assoc 159 (1971) 731-738
22. Pederson C.E., Robinson D.M., and Cole F.E. Isolation of the vaccine strain of Venezuelan equine encephalomyelitis virus from mosquitoes in Louisiana. Am J Epidemiol 95 (1972) 490-496
23. Hart M.K., Pratt W.D., Panelo F., Tammariello R., and Dertzbaugh M. Venezuelan equine encephalitis virus vaccines induce mucosal IgA responses and protection from airborne infection in BALB/c, but not C3H/HeN mice. Vaccine 15 4 (1997) 363-369
24. Ludwig G.V., Turell M.F., Vogel P., Kondig J.P., Kell W.K., Smith J.F., et al. Comparative neurovirulence of attenuated and non-attenuated strains of Venezuelan equine encephalitis virus in mice. Am J Trop Med Hyg 64 1-2 (2001) 49-55
25. Hart M.K., Caswell-Stephan K., Bakken R., Tammariello R., Pratt W.D., Davis N.L., et al. Improved mucosal protection against Venezuelan equine encephalitis virus is induced by the molecularly defined, live-attenuated V3526 vaccine candidate. Vaccine 18 26 (2000) 3067-3075
26. Pifat DY, Vogel AP. Final report: neurovirulence safety testing in rhesus macaques of a new vaccine candidate (V3526) for Venezuelan equine encephalitis virus (VEE) protocol O98-02G. United States Army Medical Research Institute of Infectious Disease, Office of Product Development and Regulatory Affairs. 2000. p. 1-93.
27. Steele K.E., Davis K.J., Stephan K., Kell W.K., Vogel P., and Hart M.K. Comparative neurovirulence and tissue tropism of wild-type and attenuated strains of Venezuelan equine encephalitis virus administered by aerosol in C3H/HeN and BALB/c mice. Vet Pathol 35 5 (1998) 386-397
28. Turell M.J., Ludwig G.V., Kondig J.P., and Smith J.F. Limited potential for mosquito transmission of genetically engineered, live-attenuated Venezuelan equine encephalitis virus vaccine candidates. Am J Trop Med Hyg 60 6 (1999) 1041-1044
29. Weaver S.C., Salas R., Rico-Hesse R., Ludwig G.V., Oberste M.S., Boshell J., et al. Re-emergence of epidemic Venezuelan equine encephalomyelitis in South America. VEE Study Group. Lancet 348 (1996) 436-440
30. Oberste M.S., Fraire M., Navarro R., Zepeda C., Zarate M.L., Ludwig G.V., et al. Association of Venezuelan equine encephalitis virus subtype 1E with two equine epizootics in Mexico. Am J Trop Med Hyg 59 (1998) 100-107